Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Hand hygiene01:23

Hand hygiene

Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Cholinergic Antagonists: Pharmacokinetics01:24

Cholinergic Antagonists: Pharmacokinetics

Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and the conjunctiva.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can life satisfaction be considered a predictor of quality of life in patients with lung cancer?

European review for medical and pharmacological sciences·2020
Same author

New insight into relaxation dynamics of an epoxy/hydroxy functionalized polybutadiene from dielectric and mechanical spectroscopy studies.

Colloid and polymer science·2014
Same author

Synergy against fungal pathogens: working together is better than working alone.

Current medicinal chemistry·2013
Same author

Effect of pressure on decoupling of ionic conductivity from structural relaxation in hydrated protic ionic liquid, lidocaine HCl.

The Journal of chemical physics·2013
Same author

The behavior and origin of the excess wing in DEET (N,N-diethyl-3-methylbenzamide).

Physical chemistry chemical physics : PCCP·2013
Same author

Heterogeneous dynamics of prototypical ionic glass CKN monitored by physical aging.

Physical review letters·2013

Related Experiment Video

Updated: Jun 14, 2026

Green Synthesis of Quinoline-Based Ionic Liquid
05:59

Green Synthesis of Quinoline-Based Ionic Liquid

Published on: September 27, 2024

Quinoline-based antifungals.

R Musiol1, M Serda, S Hensel-Bielowka

  • 1Institute of Chemistry, University of Silesia, Katowice, Poland.

Current Medicinal Chemistry
|April 10, 2010
PubMed
Summary
This summary is machine-generated.

New quinoline-based antifungal agents are being developed to overcome the limitations of current treatments, such as toxicity and drug resistance. This review explores recent advancements in designing these promising antifungal compounds.

More Related Videos

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

Related Experiment Videos

Last Updated: Jun 14, 2026

Green Synthesis of Quinoline-Based Ionic Liquid
05:59

Green Synthesis of Quinoline-Based Ionic Liquid

Published on: September 27, 2024

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds
08:54

Broth Microdilution In Vitro Screening: An Easy and Fast Method to Detect New Antifungal Compounds

Published on: February 14, 2018

Quantifying the Antifungal Activity of Peptides Against Candida albicans
06:45

Quantifying the Antifungal Activity of Peptides Against Candida albicans

Published on: January 13, 2023

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Organic Synthesis

Background:

  • Existing antifungal drugs often exhibit significant toxicity and can lead to the emergence of drug resistance.
  • Newly developed antifungal drug candidates may not always offer improved pharmacological profiles or safety.
  • The 8-hydroxyquinoline scaffold and its metal complexes have a long-standing history as effective antifungal agents.

Purpose of the Study:

  • To review recent findings in the design and development of novel quinoline-based antifungal agents.
  • To explore the structural similarities between quinoline antifungals and established drug classes like allylamines.
  • To identify emerging trends, potential molecular targets, and structure-activity relationships in quinoline antifungal research.

Main Methods:

  • Comprehensive literature review of recent studies on quinoline-based antifungal agents.
  • Analysis of structural features and synthetic strategies for novel quinoline derivatives.
  • Examination of structure-activity relationships (SAR) to guide future drug design.

Main Results:

  • Quinoline derivatives represent a 'privileged structure' in antifungal drug discovery, appearing in both natural and synthetic compounds.
  • Structural analogies with known antifungals like terbinafine highlight the potential of the quinoline core.
  • Recent research focuses on optimizing quinoline structures for enhanced antifungal activity and reduced toxicity.

Conclusions:

  • Quinoline-based compounds are a promising scaffold for developing new antifungal therapies.
  • Understanding SAR and identifying novel targets are crucial for advancing quinoline antifungal drug design.
  • Further research into quinoline derivatives could lead to more effective and safer treatments for fungal infections.